Good MorningEquity markets tried to rebound on Wednesday but stumbled after getting what they wanted: soft labor data. While the ADP and JOLTs figures suggest softening in the labor market and may lead the FOMC to cut rates sooner than expected, there is a downside that should be considered. Slowing labor market growth and business spending will impact GDP in 2024 and may lead the economy into recession. The odds of a soft landing have grown in recent months, but investors should not be sanguine, the Fed has been behind the curve since the beginning of the inflation crisis and is unlikely to proactively cut rates. Cutting too soon will result in accelerating inflation and higher rates for longer.
The S&P 500 continues hovering at critical resistance with several potential catalysts. The first comes on Friday with the NFP report, expected to show a solid job gain of 190,000, the next is the following week and includes a double-shot of inflation news, the FOMC decisions and retail sales. The CPI and PPI will most likely confirm slowing inflation but the retail sales may also confirm weak spending and lackluster holiday season. Featured: Lithium Discovery So BIG You Can't Miss it, Even From Space (*** LIMITED TIME *** Li-FT Power Ltd) 
|
Stocks | | |
If you're like most shoppers, you order many of the items you use daily online. In recent years, online shopping has evolved and adapted to people's needs, and very successful companies work exclusively online to address the specific needs of their consumers.
Savvy investors have noticed this tre... Read the Full Story |
|
From Our Partners=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>> | | | | Get the name of the stock here |
|
Stocks | | |
Looking for consumer staples dividend stocks?
When investors are uncertain, they often look to consumer staples stocks since these companies sell things we can't go without, such as food, beverages and household products.
When inflation is high, investing in consumer staples stocks with di... Read the Full Story |
|
Markets | | | Large, well-established, and financially stable businesses with a long history of reliable performance are often referred to as blue-chip companies. These companies are typically leaders in their industries and tend to have strong market positions, large market capitalizations, and robust financials... Read the Full Story |
|
From Our PartnersIf you’re looking for an INCREDIBLE deal on stocks with huge growth potential, now is the time to look at this list our team prepared.
(**By clicking the link you are subscribing to the Summa Money Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
| | Download The List With Details On Each Stock Here |
|
Markets | | |
When many investors first begin building an investment portfolio, they inadvertently veer toward the consumer staples sector. Consumer staples are companies that produce and sell essential products that people use daily, regardless of economic conditions. These companies tend to represent more sta... Read the Full Story |
|
Markets | | | Wall Street rose Thursday to snap its first three-day losing streak since Halloween.The S&P 500 climbed 36.25 points, or 0.8%, to 4,585.59. The Dow Jones Industrial Average added 62.95, or 0.2%, to 36,117.38, and the Nasdaq composite jumped 193.28, or 1.4%, to 14,339.99.Big Tech stocks helped po... Read the Full Story |
|
From Our PartnersWith so many strange events happening across the economy (longest bear market for bonds since Civil War... unprecedented bank closures... and soaring prices) – it's no wonder the richest investors are loading up on gold. But what you might not realize is there's a much better way to profit from rising gold prices – without ever touching an ETF, mining stock, or even bullion. | | | | Full details here. |
|
Markets | | |
When investing for dividends, a vital sequence is the ex dividend date vs record date. To be entitled to a company's dividend payout, an investor must hold shares through a specific day, which will vary depending on the company. Investors with long time horizons using "buy and hold" strategies don... Read the Full Story |
|
Stocks | | | Inflation gradually loosened its grip on Wall Street and the economy in 2023, raising hopes for a gentler Federal Reserve and solid gains for the market next year.Stocks rallied to their best month of the year in November as investors raised their bets that the Fed is done hiking interest rates to f... Read the Full Story |
|
Markets | | | The heads of Wall Street’s biggest banks used an appearance on Capitol Hill to plead with senators to stop the Biden administration’s proposed changes to how banks are regulated, warning that the proposals could negatively impact the economy at a time of geopolitical turmoil and inflation Read the Full Story |
|
Markets | | | Federal regulators are investigating ExxonMobil's $60 billion deal to acquire a Texas oil company in what would be one the largest mergers in the energy industry in two decades, according to securities filings.The Federal Trade Commission, which enforces federal antitrust law, has asked for addition... Read the Full Story |
|
Markets | | | A lawyer for JetBlue Airways said Tuesday that the biggest U.S. airlines are using their size to cement their dominance in a post-pandemic world, making it critical that a federal judge allow JetBlue to buy Spirit Airlines.The lawyer, Ryan Shores, said JetBlue needs Spirit to be a “viable challenger... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts. | | View Today's Stock Pick |
|
